Literature DB >> 28196252

Sofosbuvir/Velpatasvir (Epclusa) for Hepatitis C.

.   

Abstract

Entities:  

Year:  2017        PMID： 28196252     DOI： 10.1001/jama.2016.12279

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

Review 1.  Sofosbuvir/Velpatasvir for the treatment of Hepatitis C Virus infection.

Authors:  Anna Linda Zignego; Monica Monti; Laura Gragnani
Journal:  Acta Biomed       Date:  2018-10-08

2.  Real-world effectiveness of sofosbuvir plus ribavirin for chronic hepatitis C genotype 2 in Asia: a systematic review and meta-analysis.

Authors:  Bin Wei; Fanpu Ji; Yee Hui Yeo; Eiichi Ogawa; Biyao Zou; Christopher D Stave; Shuangsuo Dang; Zongfang Li; Norihiro Furusyo; Ramsey C Cheung; Mindie H Nguyen
Journal:  BMJ Open Gastroenterol       Date:  2018-06-29

3.  Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia.

Authors:  Bin Wei; Fanpu Ji; Yee Hui Yeo; Eiichi Ogawa; Christopher D Stave; Shuangsuo Dang; Zongfang Li; Norihiro Furusyo; Ramsey C Cheung; Mindie H Nguyen
Journal:  BMJ Open Gastroenterol       Date:  2018-08-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.